[1]彭 赛,卢丛兰,孙中洋.人工智能在骨质疏松症诊疗中的应用进展[J].陕西医学杂志,2024,(3):425-427,432.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.030]
　PENG Sai,LU Conglan,SUN Zhongyang.Advances in application of artificial intelligence in diagnosis and treatment of osteoporosis[J].,2024,(3):425-427,432.[doi:DOI:10.3969/j.issn.1000-7377.2024.03.030]
点击复制

人工智能在骨质疏松症诊疗中的应用进展
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年3期
页码:
425-427,432
栏目:
综 述
出版日期:
2024-03-05

文章信息/Info

Title:
Advances in application of artificial intelligence in diagnosis and treatment of osteoporosis
作者:
彭 赛1; 卢丛兰1; 孙中洋1; 2
(1.东部战区空军医院骨科,江苏 南京 210002; 2.安徽医科大学第五临床学院,安徽 合肥 230032)
Author(s):
PENG Sai; LU Conglan; SUN Zhongyang
(Department of Orthopaedics,the Air Force Hospital of the Eastern Theater Command,Nanjing 210002,China)
关键词:
骨质疏松症;  骨折;  诊断;  治疗;  人工智能;  算法
Keywords:
Osteoporosis;  Fracture;  Diagnosis;  Treatment;  Artificial intelligence;  Algorithm
分类号:
R 580
DOI:
DOI:10.3969/j.issn.1000-7377.2024.03.030
文献标志码:
A
摘要:
骨质疏松症是一种以低骨量和骨微结构退化为特点的代谢性疾病,从而导致骨折风险增加。骨质疏松性骨折通常发生在脊椎、髋关节、前臂远端和肱骨近端,但其他部位骨骼也可受累。尽管骨质疏松症的诊断是基于双能X射线吸收仪测量的骨密度(BMD)上,但多数发生骨质疏松性骨折患者的BMD尚未达到骨质疏松症的诊断标准。不管有无发生脆性骨折,骨质疏松症的诊断率仍然很低。此外,对于骨质疏松症的治疗时机、治疗对象和药物选择等诸多方面尚无标准指南。在此背景下,人工智能(AI)研发人员根据骨质疏松症的特点开发出多种算法,有望提高该疾病的诊疗水平。现就AI在骨质疏松症诊断和治疗中的最新应用进行简要概述。
Abstract:
Osteoporosis is a disease characterized by low bone mass and microarchitectural deterioration leading to increased fracture risk.Typically,osteoporotic fractures occur at the spine,hip,distal forearm,and proximal humerus,but other skeletal sites may be affected as well.Although the diagnosis of osteoporosis is based on the bone mineral density(BMD)measured by dual energy X-ray absorptiometry,the BMD of most patients with osteoporotic fractures has not yet reached the diagnostic criteria of osteoporosis.The diagnosis rate of osteoporosis remains low regardless of the presence or absence of fragility fractures.Also,there is only weak consensus among the major guidelines worldwide,when to treat,whom to treat,and which drug to use.Against this background,artificial intelligence(AI)researchers have developed a variety of algorithms according to the characteristics of osteoporosis,which is expected to improve the diagnosis and treatment of the disease.This article briefly reviews the latest application of AI in the diagnosis and treatment of osteoporosis.

参考文献/References:

[1] SONG S,GUO Y,YANG Y,et al.Advances in pathogenesis and therapeutic strategies for osteoporosis[J].Pharmacol Ther,2022,237:108168.
[2] 王猛,党星波,周永春,等.地舒单抗治疗老年性骨质疏松疗效及对患者骨密度、骨代谢的影响[J].陕西医学杂志,2023,52(10):1395-1398.
[3] 吴兴净,陶周善,龚延海,等.鲑鱼降钙素联合骨化三醇治疗老年椎体压缩性骨折伴慢性肾功能不全患者椎体成形术后骨质疏松疗效观察[J].陕西医学杂志,2022,51(9):1133-1136,1162.
[4] AYERS C,KANSAGARA D,LAZUR B,et al.Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis:A living systematic review and network meta-analysis for the American college of physicians[J].Ann Intern Med,2023,176(2):182-195.
[5] MA B,YANG J,WONG F K Y,et al.Artificial intelligence in elderly healthcare:A scoping review[J].Ageing Res Rev,2023,83:101808.
[6] SMETS J,SHEVROIA E,HUGLE T,et al.Machine learning solutions for osteoporosis:A review[J].J Bone Miner Res,2021,36(5):833-851.
[7] GREENER J G,KANDATHIL S M,MOFFAT L,et al.A guide to machine learning for biologists[J].Nat Rev Mol Cell Biol,2022,23(1):40-55.
[8] HABEHH H,GOHEL S.Machine learning in healthcare[J].Curr Genomics,2021,22(4):291-300.
[9] LECUN Y,BENGIO Y,HINTON G.Deep learning[J].Nature,2015,521(7553):436-444.
[10] LIAO T,LI L,OUYANG R,et al.Classification of asymmetry in mammography via the densenet convolutional neural network[J].Eur J Radiol Open,2023,11:100502.
[11] KANIS J A,NORTON N,HARVEY N C,et al.SCOPE 2021:A new scorecard for osteoporosis in Europe[J].Arch Osteoporos,2021,16(1):82.
[12] LEE J S,ADHIKARI S,LIU L,et al.Osteoporosis detection in panoramic radiographs using a deep convolutional neural network-based computer-assisted diagnosis system:A preliminary study[J].Dentomaxillofac Radiol,2019,48(1):20170344.
[13] LEE K S,JUNG S K,RYU J J,et al.Evaluation of transfer learning with deep convolutional neural networks for screening osteoporosis in dental panoramic radiographs[J].J Clin Med,2020,9(2):392.
[14] AREECKAL A S,KAMATH J,ZAWADYNSKI S,et al.Combined radiogrammetry and texture analysis for early diagnosis of osteoporosis using Indian and Swiss data[J].Comput Med Imaging Graph,2018,68:25-39.
[15] YANG S,YIN B,CAO W,et al.Diagnostic accuracy of deep learning in orthopaedic fractures:A systematic review and meta-analysis[J].Clin Radiol,2020,75(9):713.e17-713.e28.
[16] YASAKA K,AKAI H,KUNIMATSU A,et al.Prediction of bone mineral density from computed tomography:Application of deep learning with a convolutional neural network[J].Eur Radiol,2020,30(6):3549-3557.
[17] KRISHNARAJ A,BARRETT S,BREGMAN O,et al.Simulating dual-energy X-ray absorptiometry in CT using deep-learning segmentation cascade[J].J Am Coll Radiol.2019,16(10):1473-1479.
[18] FANG Y,LI W,CHEN X,et al.Opportunistic osteoporosis screening in multi-detector CT images using deep convolutional neural networks[J].Eur Radiol,2021,31(4):1831-1842.
[19] ZHAO Y,HUANG M,DING J,et al.Prediction of abnormal bone density and osteoporosis from lumbar spine MR using modified dixon quant in 257 Subjects with quantitative computed tomography as reference[J].J Magn Reson Imaging,2019,49(2):390-399.
[20] ZHAO Y,ZHAO T,CHEN S,et al.Fully automated radiomic screening pipeline for osteoporosis and abnormal bone density with a deep learning-based segmentation using a short lumbar mDixon sequence[J].Quant Imaging Med Surg,2022,12(2):1198-1213.
[21] GAO L,JIAO T,FENG Q,et al.Application of artificial intelligence in diagnosis of osteoporosis using medical images:A systematic review and meta-analysis[J].Osteoporos Int,2021,32(7):1279-1286.
[22] WATTS N B,CAMACHO P M,LEWIECKI E M,et al.American association of clinical endocrinologists/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 Update[J].Endocr Pract,2021,27(4):379-380.
[23] SHOBACK D,ROSEN C J,BLACK D M,et al.Pharmacological management of osteoporosis in postmenopausal women:An endocrine society guideline update[J].J Clin Endocrinol Metab,2020,105(3):48.
[24] KANIS J A,COOPER C,RIZZOLI R,et al.Executive summary of the European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Calcif Tissue Int,2019,104(3):235-238.
[25] KANIS J A,JOHANSSON H,HARVEY N C,et al.Adjusting conventional FRAX estimates of fracture probability according to the recency of sentinel fractures[J].Osteoporos Int,2020,31(10):1817-1828.
[26] DIEZ A,ADACHI J D,ADAMI S,et al.Risk factors for treatment failure with antiosteoporosis medication:The global longitudinal study of osteoporosis in women(GLOW)[J].J Bone Miner Res,2014,29(1):260-267.
[27] FRANCIS R M.Non-response to osteoporosis treatment[J].J Br Menopause Soc,2004,10(2):76-80.
[28] 屈佳乐,李刚,刘江.艾灸防治绝经后骨质疏松症研究进展[J].陕西中医,2023,44(7):983-986.
[29] TANPHIRIYAKUN T,ROJANASTHIEN S,KHUMRIN P.Bone mineral density response prediction following osteoporosis treatment using machine learning to aid personalized therapy[J].Sci Rep,2021,11(1):13811.

相似文献/References:

[1]田 鹏,蔡盈盈,孙春丽,等.衰弱对社区老年人骨折预测作用的系统评价[J].陕西医学杂志,2020,49(3):370.
[2]李 洺,赵 宇△,马 丁,等.女性绝经后骨质疏松症患者血清铁蛋白、同源拮抗物表达水平及临床意义*[J].陕西医学杂志,2020,49(10):1266.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.017]
　LI Ming,ZHAO Yu,MA Ding,et al.Expression and clinical significance of serum ferritin and B-cell lymphoma factor 2 homologous antagonist in postmenopausal women with osteoporosis[J].,2020,49(3):1266.[doi:DOI:10.3969/j.issn.1000-7377.2020.10.017]
[3]梁朝鑫,周安远,吴立蔚,等.富血小板血浆在骨科疾病治疗中的研究进展[J].陕西医学杂志,2021,50(12):1605.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.035]
　LIANG Chaoxin,ZHOU Anyuan,WU Liwei,et al.Research progress of platelet-rich plasma in treatment of orthopedic diseases[J].,2021,50(3):1605.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.035]
[4]昌 震,李大同,杨小彬,等.奇壬醇对骨质疏松症的治疗作用及机制研究进展[J].陕西医学杂志,2022,51(9):1167.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.029]
　CHANG Zhen,LI Datong,YANG Xiaobin,et al.Research progress on therapeutic effect and mechanism of Kirenol on osteoporosis[J].,2022,51(3):1167.[doi:DOI:10.3969/j.issn.1000-7377.2022.09.029]
[5]张亮亮,赵程锦,周煜虎,等.积雪草酸对大鼠绝经后骨质疏松症的治疗作用及机制研究[J].陕西医学杂志,2023,52(12):1624.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.002]
　ZHANG Liangliang,ZHAO Chengjin,ZHOU Yuhu,et al.Therapeutic effect and mechanism of asiatic acid on postmenopausal osteoporosis in rats[J].,2023,52(3):1624.[doi:DOI:10.3969/j.issn.1000-7377.2023.12.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81600694); 军委后勤科研项目(CKJ18J019,CKJ20J024,CKJ21J033)
更新日期/Last Update: 2024-03-05